These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27313279)

  • 1. Clinical trials in rheumatology. Does one size fit all?
    Tombetti E; Rovere-Querini P; Manfredi AA
    Rheumatology (Oxford); 2017 May; 56(5):675-676. PubMed ID: 27313279
    [No Abstract]   [Full Text] [Related]  

  • 2. Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
    Silman A; Rudkin S; Walley T
    Rheumatology (Oxford); 2011 Aug; 50(8):1356-7. PubMed ID: 21118870
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of biologics in rheumatology: improving the evidence base.
    Silman AJ; Ades AE
    Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv1-2. PubMed ID: 21859699
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic strategies: Ways to remission].
    Krüger K; Edelmann E
    Z Rheumatol; 2015 Jun; 74(5):386-7. PubMed ID: 26085071
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: the vital role of randomized controlled trials in Arthritis & Rheumatology.
    Solomon DH; Weinblatt ME; Bucala RJ
    Arthritis Rheumatol; 2015 Oct; 67(10):2555-6. PubMed ID: 26139424
    [No Abstract]   [Full Text] [Related]  

  • 6. Career lifetime advances in rheumatology.
    Scott DL
    Clin Med (Lond); 2010 Apr; 10(2):156-9. PubMed ID: 20437989
    [No Abstract]   [Full Text] [Related]  

  • 7. The Corrona US registry of rheumatic and autoimmune diseases.
    Kremer JM
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in pediatric rheumatology.
    Becker ML
    Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are individual patient trials (n-of-1 trials) in rheumatology worth the extra effort?
    Peloso PM
    J Rheumatol; 2004 Jan; 31(1):8-11. PubMed ID: 14705210
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.
    Pincus T; Braun J; Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-1. PubMed ID: 25365080
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric Rheumatology Collaborative Study Group - over four decades of pivotal clinical drug research in pediatric rheumatology.
    Brunner HI; Rider LG; Kingsbury DJ; Co D; Schneider R; Goldmuntz E; Onel KB; Giannini EH; Lovell DJ;
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):45. PubMed ID: 29996857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biologics and cardiovascular risk].
    Tarner IH; Müller-Ladner U; Hamm C
    Z Rheumatol; 2010 Oct; 69(8):702-6, 708-11. PubMed ID: 20862482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries.
    Carmona L; de la Vega M; Ranza R; Casado G; Titton DC; Descalzo MÁ; Gómez-Reino J
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-163-7. PubMed ID: 25365109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-TNF biologicals in therapy].
    Wollenhaupt J; Burmester GR
    Z Rheumatol; 2010 Sep; 69(7):579-80. PubMed ID: 20703491
    [No Abstract]   [Full Text] [Related]  

  • 16. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salvage therapy and difficult treatment situations].
    Schmidt RE; Kötter I
    Z Rheumatol; 2016 Dec; 75(10):954-955. PubMed ID: 27807629
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatology training and research in Iran.
    Khabbazi A; Soroosh M
    Rheumatol Int; 2019 Aug; 39(8):1307-1319. PubMed ID: 31111293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history of the use of sulphasalazine in rheumatology.
    Amos RS
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():2-6. PubMed ID: 8535643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remittive agents in pediatric rheumatology.
    Singer NG; Scalzi LV
    Curr Opin Rheumatol; 2004 Sep; 16(5):571-6. PubMed ID: 15314497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.